SV2017005586A - Procesos e intermediarios para la preparacion de {1- (etilsulfonil) -3- [4 -(7h -pirrolo [2, 3-d] pirimidin -4- il) -1h -pirazol -1- il] azetidin -3- il} acetonitrilo - Google Patents

Procesos e intermediarios para la preparacion de {1- (etilsulfonil) -3- [4 -(7h -pirrolo [2, 3-d] pirimidin -4- il) -1h -pirazol -1- il] azetidin -3- il} acetonitrilo

Info

Publication number
SV2017005586A
SV2017005586A SV2017005586A SV2017005586A SV2017005586A SV 2017005586 A SV2017005586 A SV 2017005586A SV 2017005586 A SV2017005586 A SV 2017005586A SV 2017005586 A SV2017005586 A SV 2017005586A SV 2017005586 A SV2017005586 A SV 2017005586A
Authority
SV
El Salvador
Prior art keywords
etilsulfonil
pirimidin
pirrolo
pirazol
intermediaries
Prior art date
Application number
SV2017005586A
Other languages
English (en)
Inventor
Michael Edward Kobierski
Michael E Kopach
Joseph R Martinelli
David Lee Varie
Thomas Michael Wilson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56204068&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2017005586(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SV2017005586A publication Critical patent/SV2017005586A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A PROCESOS E INTERMEDIARIOS PARA LA PREPARACIÓN DE {1 -(ETILSULFONIL)-3-[4-(7H- PIRROLO [2,3-D] PIRIMIDIN-4-IL)-1 H-PIRAZOL-1 -IL]AZETIDIN-3- IL} ACETONITRILO
SV2017005586A 2015-06-19 2017-12-11 Procesos e intermediarios para la preparacion de {1- (etilsulfonil) -3- [4 -(7h -pirrolo [2, 3-d] pirimidin -4- il) -1h -pirazol -1- il] azetidin -3- il} acetonitrilo SV2017005586A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562182040P 2015-06-19 2015-06-19

Publications (1)

Publication Number Publication Date
SV2017005586A true SV2017005586A (es) 2018-04-24

Family

ID=56204068

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2017005586A SV2017005586A (es) 2015-06-19 2017-12-11 Procesos e intermediarios para la preparacion de {1- (etilsulfonil) -3- [4 -(7h -pirrolo [2, 3-d] pirimidin -4- il) -1h -pirazol -1- il] azetidin -3- il} acetonitrilo

Country Status (26)

Country Link
US (2) US20180134713A1 (es)
EP (1) EP3310781A1 (es)
JP (1) JP2018519280A (es)
KR (1) KR20180008637A (es)
CN (1) CN107660206A (es)
AR (1) AR104918A1 (es)
AU (1) AU2016280815A1 (es)
BR (1) BR112017024613A2 (es)
CA (1) CA2984627A1 (es)
CL (1) CL2017003112A1 (es)
CO (1) CO2017013226A2 (es)
CR (1) CR20170533A (es)
DO (1) DOP2017000300A (es)
EA (1) EA201792308A1 (es)
EC (1) ECSP17083426A (es)
HK (1) HK1248699A1 (es)
IL (1) IL255386A0 (es)
MA (1) MA45901A (es)
MX (1) MX2017015837A (es)
NZ (1) NZ736999A (es)
PE (1) PE20180504A1 (es)
PH (1) PH12017502360A1 (es)
SV (1) SV2017005586A (es)
TN (1) TN2017000530A1 (es)
TW (1) TWI622591B (es)
WO (1) WO2016205487A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108341818A (zh) * 2017-01-21 2018-07-31 南京华威医药科技开发有限公司 巴瑞克替尼及其磷酸盐的新晶型及其制备方法
CA3055233C (en) 2017-01-23 2022-08-09 Shanghai Longwood Biopharmaceuticals Co., Ltd. Jak kinase inhibitor and preparation method and use thereof
CN106946917B (zh) * 2017-03-20 2019-06-11 杭州科巢生物科技有限公司 一种jak抑制剂巴瑞替尼及其中间体的新合成方法
CN107739328B (zh) * 2017-11-22 2020-03-20 海化生命(厦门)科技有限公司 用于合成巴瑞替尼的关键中间体1的制备方法
CN108129482A (zh) * 2017-12-13 2018-06-08 江苏中邦制药有限公司 一种巴瑞替尼的制备方法
US10766900B2 (en) 2017-12-29 2020-09-08 Formosa Laboratories, Inc. Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof
WO2020072870A1 (en) 2018-10-05 2020-04-09 Johnson Matthey Public Limited Company Co-crystal forms of baricitinib
TW202033198A (zh) 2018-10-17 2020-09-16 美商美國禮來大藥廠 以巴瑞克替尼(baricitinib)治療原發性膽汁性膽管炎及原發性硬化性膽管炎
EP3958968A1 (en) 2019-04-24 2022-03-02 Elanco Us Inc. A 7h-pyrrolo[2,3-d]pyrimidine jak-inhibitor
AU2022319128A1 (en) 2021-07-30 2024-01-18 Eli Lilly And Company Treatment of hand eczema with baricitinib

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821374A (en) * 1995-11-21 1998-10-13 Hoffmann-La Roche Inc. Process for the oxidation of alcohols
SG191660A1 (en) * 2008-03-11 2013-07-31 Incyte Corp Azetidine and cyclobutane derivatives as jak inhibitors
CA2796388A1 (en) * 2010-04-14 2011-10-20 Array Biopharma Inc. 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases
CN102557901B (zh) * 2010-12-15 2014-06-11 上海医药工业研究院 6-氯己醛的制备方法
SG10201707259PA (en) * 2013-03-06 2017-10-30 Incyte Corp Processes and intermediates for making a jak inhibitor
CN105541891B (zh) * 2016-02-04 2017-11-28 东南大学 巴瑞替尼的中间体及其制备方法及由该中间体制备巴瑞替尼的方法

Also Published As

Publication number Publication date
TW201712015A (zh) 2017-04-01
TWI622591B (zh) 2018-05-01
HK1248699A1 (zh) 2018-10-19
EP3310781A1 (en) 2018-04-25
US20180134713A1 (en) 2018-05-17
ECSP17083426A (es) 2018-02-28
EA201792308A1 (ru) 2018-05-31
WO2016205487A1 (en) 2016-12-22
MA45901A (fr) 2019-06-19
US20190062337A1 (en) 2019-02-28
JP2018519280A (ja) 2018-07-19
KR20180008637A (ko) 2018-01-24
CL2017003112A1 (es) 2018-06-01
TN2017000530A1 (en) 2019-04-12
CN107660206A (zh) 2018-02-02
BR112017024613A2 (pt) 2018-07-31
AR104918A1 (es) 2017-08-23
NZ736999A (en) 2019-05-31
MX2017015837A (es) 2018-04-10
CO2017013226A2 (es) 2018-03-28
CA2984627A1 (en) 2016-12-22
AU2016280815A1 (en) 2017-11-23
CR20170533A (es) 2018-01-25
PH12017502360A1 (en) 2018-06-25
DOP2017000300A (es) 2018-01-31
IL255386A0 (en) 2017-12-31
PE20180504A1 (es) 2018-03-09

Similar Documents

Publication Publication Date Title
SV2017005586A (es) Procesos e intermediarios para la preparacion de {1- (etilsulfonil) -3- [4 -(7h -pirrolo [2, 3-d] pirimidin -4- il) -1h -pirazol -1- il] azetidin -3- il} acetonitrilo
CL2016001871A1 (es) Anticuerpos humanos para pd-1
MA44702A (fr) Compositions de suspension à libération prolongée
CL2016003145A1 (es) Compuestos de [1,2,4]triazol sustituido
MA40774A (fr) Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
DK3474804T4 (da) Medicinsk forbinding
DK3298027T3 (da) Anthelmintiske depsipeptidforbindelser
MA41140A (fr) Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg
DK3653599T3 (da) Krystallinsk tapentadolphosphat
DK3244717T3 (da) Jordbearbejdningsredskab
EP3218703A4 (en) Determining the identity of modified compounds
GB2556654B (en) Production of alkylated compounds
BR112016019246A2 (pt) processo paraa fabricação de hidroclorofluoro-olefinas
ES2789757T8 (es) Herramienta de conformado
ITUA20161990A1 (it) Mangiatoia per avicoltura
ITBA20140018A1 (it) Macchinario per la produzione di stracciatella
ITUA20161550A1 (it) Procedimento per la produzione di RNA
DK3559403T3 (da) Forbedret værktøj
IT201700050223A1 (it) Procedimento per la preparazione di dexlansoprazolo cristallino
DE112017000878A5 (de) Kupplungsgeberzylinder
EA201791596A1 (ru) Пиразоловые соединения
KR102150179B9 (ko) 나트륨 시아나이드의 제조 방법
ES1108955Y (es) Horma para la personalizacion de calzados
ES1105180Y (es) Insertos antivibración
ITUA20164040A1 (it) Procedimento per la preparazione di polimorfo a